Status:
RECRUITING
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Gastrostomy
Gastric
Eligibility:
All Genders
18+ years
Brief Summary
To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.
Detailed Description
Primary Objective: Delineate the short-term appetite of patients who undergo minimally-invasive proximal gastrectomy (MIPG) and compare them with those of patients with gastric and gastroesophageal a...
Eligibility Criteria
Inclusion
- Inclusion:
- Able to speak and read English, Spanish, Japanese or Korean
- Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
- Age ≥ 18
- Exclusion:
- Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
- Participants with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
- Participants deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
- Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)
Exclusion
Key Trial Info
Start Date :
May 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05205343
Start Date
May 11 2022
End Date
May 31 2026
Last Update
October 27 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
2
M D Anderson Cancer Center
Houston, Texas, United States, 77030
3
Keio University School of Medicine
Tokyo, Japan, 1600016
4
Yonsei University College of Medicine
Soeul, South Korea, 03722